Feds ramp up nursing home sanctions for poor care performance
By
Alicia Lasek
Oct 24, 2022
The Centers for Medicare & Medicaid Services will more aggressively enforce accountability in its Special Focus Facilities (SFF) Program, the Biden Administration said Friday.
CDC releases vaccine coverage data for healthcare personnel, 2021-2022
By
Alicia Lasek
Oct 24, 2022
A survey of U.S. workers, including LTC staff members, has revealed flu and COVID-19 vaccination trends. Employer requirements helped to move the needle, the researchers say.
Clinical briefs for Monday, Oct. 24
By
Alicia Lasek
Oct 24, 2022
Experts offer compliance guidance on trauma care, drug-reduction as deadline hits … Need a PDPM boost? A new study points to physiatrists for $34,000 monthly kick … CDC advisers vote to add COVID vaccinations...
Frailty and dementia a big factor in seniors’ one-year surgery outcomes: study
By
Alicia Lasek
Oct 21, 2022
Frailty and dementia appear to have an outsized effect on mortality after surgery, a first-of-its-kind study finds. The results highlight the importance of geriatric conditions in surgical prognosis, the...
Beta blockers may reduce mortality in patients with heart disease and dementia
By
Alicia Lasek
Oct 21, 2022
Beta blocker therapy is associated with significantly lower short- and long-term mortality rates among all patients with a common type of heart failure, investigators say.
Clinical briefs for Friday, Oct. 21
By
Alicia Lasek
Oct 21, 2022
Use peer mentoring, not a ‘diet of distraction’ to combat isolation in long-term care … Behavioral health drug prescriptions surged during pandemic, Medicare data show … Diabetes drugs linked to...
Shingrix shingles vaccine protects seniors for 10 years, new data show
By
Alicia Lasek
Oct 20, 2022
Older adults have long-term protection against shingles after receiving Shingrix, which has demonstrated 80% efficacy in ongoing clinical trials, the drug’s maker reports.
U.S. frontline workers have milder COVID cases after vaccination: study
By
Alicia Lasek
Oct 20, 2022
The workers, including healthcare personnel, had significantly milder infections and lower viral loads after receiving a COVID-19 mRNA vaccination when compared to their unvaccinated peers.
FDA authorizes Novavax’s non-mRNA vaccine as COVID booster for adults
By
Alicia Lasek
Oct 20, 2022
The Food and Drug Administration has expanded the authorization for Novavax’s COVID-19 vaccine, the agency announced Wednesday.
Clinical briefs for Thursday, Oct. 20
By
Alicia Lasek
Oct 20, 2022
FDA approves first OTC molecular test for COVID … Updated COVID boosters should protect against quickly emerging strains, experts say … Joanne Pike named CEO of Alzheimer’s Association … Signify...